DRUG/DEVICE

Treprostinil inhalation solution

ROUTE OF ADMINISTRATION

Inhaled

THERAPEUTIC PLATFORM

Tyvaso®

TERRITORY

Worldwide

STATUS

Phase 3

Tyvaso® for idiopathic pulmonary fibrosis (IPF) is investigational and not FDA approved.